Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | CCR4 | P51679 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 2/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.33 |
| ▸ | HAO1 | Q9UJM8 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313040 | 0.98 | CYP1A2 (0.38) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL27588098 | 0.84 | CYP1A2 (0.39) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL10247168 | 0.82 | ALDH1A1 (0.39) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL313442 | 0.81 | CYP1A2 (0.38) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL2624132 | 0.81 | AURKA (0.39) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL13147619 | 0.81 | CYP1A2 (0.38) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| Potassium Ion SCHEMBL22518563 | 0.79 | CYP1A2 (0.37) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL2628929 | 0.78 | CYP1A2 (0.42) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL26448521 | 0.78 | NTRK1 (0.41) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 | |
| SCHEMBL12101028 | 0.75 | PLA2G4A (0.47) | CYP1A2CYP2D6CYP2C9GRM1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101977915-B | Macrocyclic serine protease inhibitors | IDENIX PHARMACEUTICALS INC (US) | 2014-08-13 | — | — | CN | disclosed |
| EP-2393493-A1 | COMPOUNDS | GlaxoSmithKline LLC (US) | 2011-12-14 | — | — | EP | disclosed |
| CN-101977915-A | Macrocyclic serine protease inhibitors | IDENIX PHARMACEUTICALS INC (US) | 2011-02-16 | — | — | CN | disclosed |
| US-20100196321-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2010-08-05 | — | — | US | disclosed |
| WO-2010088394-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196321-A1 | COMPOUNDS | HAVCR2, ACE, ACE2 | CYP1A2 51/4885CYP2D6 47/4885CYP2C9 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.